No Detail Found!

Comparative effect of preoperative oral pregabalin 50 mg vs. 75 mg on nerve growth factor (NGF) levels in parturients undergoing cesarean section

Author(s)
Muhammad Ramli Ahmad Department of Anesthesiology, Intensive Therapy, & Pain Management Faculty of Medicine, Hasanuddin University/ Wahidin Sudirohusodo Hospital,Makassar, Indonesia, 90245,
Muhammad Wirawan Harahap Department of Anesthesiology, Intensive Therapy, & Pain Management Faculty of Medicine, Hasanuddin University/ Wahidin Sudirohusodo Hospital,Makassar, Indonesia, 90245,
Nur Surya Wirawan Department of Anesthesiology, Intensive Therapy, & Pain Management Faculty of Medicine, Hasanuddin University/ Wahidin Sudirohusodo Hospital,Makassar, Indonesia, 90245,
Abstract
Background & objectives: Postoperative pain after cesarean section (CS) is a crucial problem faced by the parturients. Pregabalin is a choice of preventive analgesia to reduce neuropathic pain, inflammation, tissue irritation, and post-cesarean section pain. The purpose of this study was to compare the effect of giving pregabalin 50 mg or 75 mg in combination with paracetamol 1 g on nerve growth factor (NGF) levels after cesarean section. Methodology: A prospective, comparative model was used in this study. The study took place at Mother and Children Hospital of Sitti Khadijah I, Makassar, Indonesia. A total of 30 patients who underwent CS were randomly divided into two groups; group P1 who received pregabalin 50 mg orally and 1 g paracetamol intravenously, 1 h before surgery (n = 15), and group P2 who received pregabalin 75 mg orally and 1 g paracetamol intravenously, 1 h before surgery (n = 15). Nerve Growth Factor (NGF) levels were measured 2 h before surgery, and at 4 and 6 h post-surgery. Data were analyzed by the Mann-Whitney test using SPSS 26.0. Results: There was a decrease in NGF levels in the pregabalin 75 mg group at 6 h post-surgery, while in the pregabalin 50 mg group it tended to increase at 4 and 6 h post-surgery. In the pregabalin 50 mg group, there was a significant increase in NGF levels from measurements of NGF1 to NGF2 and NGF0 to NGF2 (P < 0.05), whereas, in the pregabalin 75 mg group, there was a significant decrease in NGF levels from measurements of NGF1 to NGF2 and NGF0 to NGF2 (P < 0.05). Conclusion: The combination of pregabalin 75 mg orally with paracetamol 1 g intravenously is effective as perioperative multimodal analgesia by reducing nerve growth factor levels after cesarean section surgery. Abbreviations: BDNF- brain-derived neurotrophic factor; CS- Cesarean section; GABA- Gamma Amino Butyric Acid; NGF- Nerve Growth Factor
Publication Details
Page(s) 721-725
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
Nerve Growth Factor (NGF), Cesarean section, Pregabalin, Postoperative
References
Joshi GP,Schug SA,Kehlet H .2014 .Procedure-specific pain management and outcome strategies. Best Pract Res Clin Anaesthesiol, 03 : 191-201.
Pogatzki-Zahn EM,Segelcke D,Schug SA .2017 .Postoperative pain-from mechanisms to treatment. Pain Rep, 2 : e588.
. .. [PubMed] DOI: 10.1097/PR9, : .
. .Study to compare the effect of oral, rectal and intravenous infusion of paracetamol for postoperative analgesia in women undergoing cesarean section under spinal anesthesia. Anesth, 4 : .
Denk F,Bennett DL,McMahon SB .2017 .Nerve Growth Factor and Pain Mechanisms. Annu Rev Neurosci, 40 : 307-325.
. .. , 072116 : .
McKelvey L,Shorten GD,O'Keeffe GW .2013 .Nerve growth factormediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem, 124 : 276-289.
Neuron .2019 .. , 02 : 783-95.
.2020 .Nerve growth factor signaling and its contribution to pain. J Pain Res, 13 : 1223-41.
Carvalho B,Clark DJ,Angst MS .2008 .Local and Systemic Release of Cytokines, Nerve Growth Factor, Prostaglandin E2, and Substance P in Incisional Wounds and Serum Following Cesarean Delivery. J Pain, 02 : 650-657.
Kivitz AJ,Gimbel JS,Bramson C,Nemeth MA,Keller DS,Brown MT .2013 .Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain, 03 : 1009-1021.
Lane NE,Schnitzer TJ,Birbara CA,Mokhtarani M,Shelton DL,Smith MD .2010 .Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med, 363 : 1521-31.
Chincholkar M. .2018 .Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review. Br J Anaesth, 02(6) : 1315-34.
Chang DS,Hsu E,Hottinger DG,Cohen SP .2016 .Anti-nerve growth factor in pain management: current evidence. J Pain Res, 9 : 373-383.
Aloe L,Rocco ML,Bianchi P,Manni L .2012 .Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med, 10 : 1479.
Lin CL,Heron P,Hamann SR,Smith GM .2014 .Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord. Neuroscience, 04 : 76-87.
0

Citations

0

Downloads

111

Views